Skip to main content
Caplight Logo









Sintra Limited

Sintra Limited

Overview

Sintra Limited is a global frontier-technology investor backing breakthrough companies in biotech, advanced computing, and blockchain-enabled infrastructure.

Portfolio Companies

1

Investments

Sintra Limited investments
CompanyDateStageLead
Captain T Cell GmbHNov 2025Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Sintra Limited based?

Headquarters information for Sintra Limited is not publicly available.

When was Sintra Limited founded?

Founding year information for Sintra Limited is not publicly available.

How many portfolio companies does Sintra Limited have?

Sintra Limited has 1 portfolio company in Caplight's dataset.

What are some companies in Sintra Limited's portfolio?

Portfolio companies visible on Caplight include Captain T Cell GmbH.

What was Sintra Limited's most recent investment shown here?

Sintra Limited's most recent investment in this portfolio sample was in Captain T Cell GmbH in 2025.

What sectors does Sintra Limited focus on?

Sintra Limited focuses on Healthcare & Life Sciences.

What company stages does Sintra Limited focus on?

Sintra Limited typically invests at the Early stage.

Firmographic Details

Headquarters—
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?